Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Expression of BRCA1, HER-1 (EGFR) and HER-2 in Sporadic Breast Cancer and Relationships to Other Clinicopathological Prognostic Features

YAN ANSQUER, LAURENT MANDELBROT, THÉRESE LEHY, LAURENCE SALOMON, CAROLINE DHAINAUT, PATRICK MADELENAT, GÉRARD FELDMANN and FRANCINE WALKER
Anticancer Research November 2005, 25 (6C) 4535-4541;
YAN ANSQUER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: yan.ansquer{at}lmr.ap-hop-paris.fr
LAURENT MANDELBROT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
THÉRESE LEHY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LAURENCE SALOMON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CAROLINE DHAINAUT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PATRICK MADELENAT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GÉRARD FELDMANN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FRANCINE WALKER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 25 no. 6C 4535-4541
PMID 
16334138

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 2, 2005
  • Accepted September 5, 2005
  • Published online November 1, 2005.

Copyright & Usage 
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. YAN ANSQUER1,5,
  2. LAURENT MANDELBROT1,
  3. THÉRESE LEHY6,
  4. LAURENCE SALOMON2,
  5. CAROLINE DHAINAUT4,
  6. PATRICK MADELENAT4,
  7. GÉRARD FELDMANN5 and
  8. FRANCINE WALKER3,6
  1. 1Hôpital Louis Mourier, Service de Gynécologie Obstétrique, 178 rue des Renouillers 92 701, Colombes Cedex
  2. 2Hôpital Louis Mourier, Département de Santé Publique, 178 rue des Renouillers 92 701, Colombes Cedex
  3. 3Hôpital Bichat, Service d'anatomopathologie, 46 rue Henri-Huchard, 75 018 Paris
  4. 4Hôpital Bichat, Service de Gynécologie Obstétrique, 46 rue Henri-Huchard, 75 018 Paris
  5. 5INSERM U481, faculté de Médecine Xavier Bichat, 16 rue Henri Huchard, 75018 Paris, France
  6. 6INSERM U 410, faculté de Médecine Xavier Bichat, 16 rue Henri Huchard, 75018 Paris, France
  1. Correspondence to: Yan Ansquer, Hôpital Louis Mourier, Service de Gynécologie Obstétrique, 178 rue des Renouillers, 92 701 Colombes Cedex, France. Tel: 00 33 1 47 60 63 40, Fax: 00 33 1 47 60 63 38, e-mail: yan.ansquer{at}lmr.ap-hop-paris.fr

Statistics from Altmetric.com

Cited By...

  • 21 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 25, Issue 6C
1 Nov 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Expression of BRCA1, HER-1 (EGFR) and HER-2 in Sporadic Breast Cancer and Relationships to Other Clinicopathological Prognostic Features
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Expression of BRCA1, HER-1 (EGFR) and HER-2 in Sporadic Breast Cancer and Relationships to Other Clinicopathological Prognostic Features
YAN ANSQUER, LAURENT MANDELBROT, THÉRESE LEHY, LAURENCE SALOMON, CAROLINE DHAINAUT, PATRICK MADELENAT, GÉRARD FELDMANN, FRANCINE WALKER
Anticancer Research Nov 2005, 25 (6C) 4535-4541;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Expression of BRCA1, HER-1 (EGFR) and HER-2 in Sporadic Breast Cancer and Relationships to Other Clinicopathological Prognostic Features
YAN ANSQUER, LAURENT MANDELBROT, THÉRESE LEHY, LAURENCE SALOMON, CAROLINE DHAINAUT, PATRICK MADELENAT, GÉRARD FELDMANN, FRANCINE WALKER
Anticancer Research Nov 2005, 25 (6C) 4535-4541;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Distinct Roles for Rho Versus Rac/Cdc42 GTPases Downstream of Vav2 in Regulating Mammary Epithelial Acinar Architecture
  • Pregnancy and the risk of breast cancer
  • HER2 testing in the UK: consensus from a national consultation
  • Modeling Breast Cancer-Associated c-Src and EGFR Overexpression in Human MECs: c-Src and EGFR Cooperatively Promote Aberrant Three-dimensional Acinar Structure and Invasive Behavior
  • Google Scholar

More in this TOC Section

  • Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort
  • Unfavorable Outcomes of T3N0 Remnant Gastric Cancer After Distal Gastrectomy
  • Circulating Tumor DNA Methylation Level Is a More Accurate Prognostic Biomarker in Colon Cancer
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire